Literature DB >> 16380818

The anti-death machinery in IKK/NF-kappaB signaling.

Jun-Li Luo1, Hideaki Kamata, Michael Karin.   

Abstract

The most extensively studied function of NF-kappaB is its ability to promote cell survival through induction of target genes, whose products inhibit various aspects of the apoptotic machinery in both normal and malignant cells. Recent studies, however, indicate that NF-kappaB activation can also suppress programmed necrosis through induction of genes encoding anti-oxidant proteins. Since tumor cells often use NF-kappaB pathway as a shield to escape the killing of conventional anti-cancer therapies, intervention of IKK/NF-kappaB signaling would be a promising option to improve the efficacy of cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380818     DOI: 10.1007/s10875-005-8217-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  121 in total

Review 1.  Caspase-independent cell death in T lymphocytes.

Authors:  Marja Jäättelä; Jürg Tschopp
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

2.  Cell signalling: cell survival and a Gadd45-factor deficiency.

Authors:  Arshad Amanullah; Naiyer Azam; Arthur Balliet; Christine Hollander; Barbara Hoffman; Albert Fornace; Dan Liebermann
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

Review 3.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

Authors:  Y Yamada; I Kirillova; J J Peschon; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.

Authors:  A M Verhagen; P G Ekert; M Pakusch; J Silke; L M Connolly; G E Reid; R L Moritz; R J Simpson; D L Vaux
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

7.  c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration.

Authors:  Robert F Schwabe; Cynthia A Bradham; Tetsuya Uehara; Etsuro Hatano; Brydon L Bennett; Robert Schoonhoven; David A Brenner
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

8.  Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity.

Authors:  V Goossens; J Grooten; K De Vos; W Fiers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  A JNK-dependent pathway is required for TNFalpha-induced apoptosis.

Authors:  Yibin Deng; Xiaoyang Ren; Lin Yang; Yahong Lin; Xiangwei Wu
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

10.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.

Authors:  N Zamzami; P Marchetti; M Castedo; D Decaudin; A Macho; T Hirsch; S A Susin; P X Petit; B Mignotte; G Kroemer
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  45 in total

1.  C1q and TNF related protein 1 regulates expression of inflammatory genes in vascular smooth muscle cells.

Authors:  Dough Kim; Seung-Yoon Park
Journal:  Genes Genomics       Date:  2018-11-24       Impact factor: 1.839

2.  Effects of PDTC on NF-κB expression and apoptosis in rats with severe acute pancreatitis-associated lung injury.

Authors:  Shihai Kan; Hongying Zhou; Changzhu Jin; Huijun Yang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Resolution of organ fibrosis.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

4.  Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.

Authors:  Juan Du; Jun Huo; Jun Shi; Zhengang Yuan; Chunyang Zhang; Weijun Fu; Hua Jiang; Qing Yi; Jian Hou
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

Review 5.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

Review 6.  Ovarian cancer stem cells and inflammation.

Authors:  Gil Mor; Gang Yin; Ilana Chefetz; Yang Yang; Ayesha Alvero
Journal:  Cancer Biol Ther       Date:  2011-04-15       Impact factor: 4.742

7.  Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.

Authors:  El-Shaimaa A Arafa; Qianzheng Zhu; Bassant M Barakat; Gulzar Wani; Qun Zhao; Mohamed A El-Mahdy; Altaf A Wani
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

8.  Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.

Authors:  Lars Vereecke; Mozes Sze; Conor Mc Guire; Brecht Rogiers; Yuanyuan Chu; Marc Schmidt-Supprian; Manolis Pasparakis; Rudi Beyaert; Geert van Loo
Journal:  J Exp Med       Date:  2010-06-07       Impact factor: 14.307

9.  Tanshinone IIA protects H9c2 cells from oxidative stress-induced cell death via microRNA-133 upregulation and Akt activation.

Authors:  Yunfei Gu; Zhuo Liang; Haijun Wang; Jun Jin; Shouyan Zhang; Shufeng Xue; Jianfeng Chen; Huijuan He; Kadan Duan; Jing Wang; Xuewei Chang; Chunguang Qiu
Journal:  Exp Ther Med       Date:  2016-05-26       Impact factor: 2.447

10.  Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation.

Authors:  Baohua Wang; Jayant Shravah; Honglin Luo; Koen Raedschelders; David D Y Chen; David M Ansley
Journal:  Biochem Biophys Res Commun       Date:  2009-08-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.